arrow
B

Brian Lam

University of Cambridge
H指数:49
被引数:7,729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide mapping of common and rare variant effects on adiposity across childhood

全基因组范围绘制儿童期肥胖的常见和稀有变异效应图谱

2026-09-250
OAAI
The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation

微生物色氨酸代谢物吲哚作用于胃肠道,通过增强GLP-1分泌和l细胞分化来改善糖尿病小鼠模型中的葡萄糖稳态

2026-03-040
OAAI
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

达格列净在心血管风险患者(无论是否患有2型糖尿病)中的心血管-肾脏效应:一项随机、双盲、安慰剂对照试验的结果

2026-02-010
PRE
Canine genome-wide association study identifies DENND1B as an obesity gene in dogs and humans

犬全基因组关联研究将<i>DENND1B</i>确定为狗和人类中的肥胖基因

Science
IF45.8
2025-03-280
PRE
Overexpression of Igf2-derived Mir483 inhibits Igf1 expression and leads to developmental growth restriction and metabolic dysfunction in mice
2024-09-011
OAAI
Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation
2024-05-012
OAAI
Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

BSN中的蛋白质截断变体与严重的成人肥胖,2型糖尿病和脂肪肝疾病有关

2024-04-042
OAAI
Prevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty

患有生长和青春期体质延迟的患者中MC3R有害变体的患病率

2023-06-207
OA
Biallelic Mutations in P4HTM Cause Syndromic Obesity
2023-04-217
OAAI
Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression

肥胖药物lorcaserin激活脑干GLP-1神经元以减少食物摄入并增强GLP-1受体激动剂诱导的食欲抑制

2023-02-0120
OAAI
HypoMap-a unified single-cell gene expression atlas of the murine hypothalamus
2022-10-2081
OAAI